Tag: Business

news-05112024-232810

Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation

Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...
news-27112024-175935

Biotech News Roundup: Stay Updated on the Latest Developments in the Industry

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...
news-29112024-062000

AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger

Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
the-main-target-and-focus-the-article-focuses-on-key-figures-attending-the-jp-morgan-healthcare-conference-on-day-2new-title-highlights-from-jp-morgan-healthcare-conference-day-2

The Main Target and Focus: The article focuses on key figures attending the J.P....

Highlights from J.P. Morgan Healthcare Conference Day 2 The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
news-09112024-221219

Biotech Analyst and CEO Discuss Election Results: Insights from Brian Skorney and Daphne Zohar

Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...
news-22112024-082138

Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
news-20112024-062138

RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability

Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
news-12112024-102000

Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update

Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
news-01122024-072554

Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates

Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...
news-06112024-052955

Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees

Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
unveiling-jpm-day-1-a-comprehensive-overview-for-nvestors

Unveiling JPM Day 1: A Comprehensive Overview for Investors

Unveiling JPM Day 1: A Comprehensive Overview for Investors Welcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...